3,4-methylenedioxyamphetamine has been researched along with Anterior Choroidal Artery Infarction in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This drug abuse is rarely reported spontaneously." | 1.29 | [Epileptic insults, cerebral infarction and rhabdomyolysis as complications of amphetamine use]. ( Korten, JJ; Roebroek, RM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manchanda, S | 1 |
| Connolly, MJ | 1 |
| Roebroek, RM | 1 |
| Korten, JJ | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Cerebral infarction in association with Ecstasy abuse.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Cerebral Infarction; Designer Drugs; Humans; Male; N-Methyl-3, | 1993 |
[Epileptic insults, cerebral infarction and rhabdomyolysis as complications of amphetamine use].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Cerebral Infarction; Designer Drugs; Epilepsy, Generalize | 1996 |